In 2020, the global laparoscopic surgical robotic device market will be severely impacted by the COVID-19 pandemic but will nevertheless still grow strongly through 2029. This will be driven by rising robotic-assisted procedure volumes, growing demand for minimally invasive surgery, increasing acceptance and adoption of surgical robotic technology, the launch of new and innovative robotic systems, and an increase in clinical evidence that supports the benefits of robotic surgery.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for laparoscopic surgical robotic devices in the US, Europe, and the Asia Pacific region across a 10-year period.
The COVID-19 pandemic will affect the laparoscopic surgical robotic device market.
To what extent will the COVID-19 pandemic impact the laparoscopic surgical robotic device market in US?
Which procedures are going to be affected the most during the pandemic?
The US laparoscopic surgical robotic device market will grow strongly through 2029.
What is driving such a strong market growth?
How does growth vary between product segments?
Robotic-assisted procedures will see rapid growth globally through 2029.
Which surgical specialty will see the most growth in terms of procedure volumes?
Is the uptake of robotic surgery occurring in specific indications?
How do the volume and growth of robotic-assisted procedures vary between different geographies?
- Laparoscopic Surgical Robotic Devices - Market Insights - Global
Author(s): Lucy Sha Guan, MSc
Lucy Guan is a senior analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, with extensive knowledge in the markets for endoscope servicing, video and high-tech hardware devices, and laparoscopic devices. Lucy holds an Honors Bachelor's degree in Biochemistry and Health & Disease and a Master's degree in Medical Science from the University of Toronto.